10.3389/fphar.2022.910292 85 LiH.LiY.YuY.RenX.YangC.JinW.et al (2024a)
GLP-1 RAs, by improving metabolic parameters, reduce the risk of obesity-related comorbidities like type 2 diabetes and cardiovascular issues
Within cells, cysteine participates in cell metabolism, whereas upon cell exit, cysteine is oxidized into cystine and rejoins the circulatory system
Our advanced EMSculpt Neo treatments are essential for preserving and building muscle during your weight loss journey: Counteracting Documented Muscle Loss : Studies show that up to 20-30% of weight lost on GLP-1 medications can be muscle tissueEMSculpt Neo directly addresses this concern by forcing muscle growth even during caloric deficit Simultaneous Fat Reduction and Muscle Building : This groundbreaking technology combines High-Intensity Focused Electromagnetic (HIFEM+) energy with radiofrequency to simultaneously reduce fat cells and build muscle mass Supramaximal Muscle Contractions : Induces muscle contractions that are impossible to achieve through voluntary exerciseup to 24,000 contractions per 30-minute sessionhelping to build and strengthen areas affected by weight loss Metabolic Protection : By preserving and increasing muscle mass, EMSculpt Neo helps maintain a higher metabolic rate, supporting long-term weight management after GLP-1 therapy Enhanced Body Definition : Particularly effective for abdominal definition, buttocks lifting, arm toning, and thigh sculpting For GLP-1 patients, EMSculpt Neo isnt just about aestheticsits an essential component of a healthy weight loss journey, ensuring that the weight you lose comes primarily from fat tissue while preserving the lean muscle mass critical for long-term metabolic health
In 537 patients with type 2 diabetes (85% treatment-naive), the trial showed HbA1c reductions up to 2.0% and weight loss up to 16.8% at 40 weeks, with no plateau
